Hyperfine, Inc. (HYPR)
After hours:
| Previous close | 0.8310 |
| Open | 0.8500 |
| Bid | 0.8450 x 1000 |
| Ask | 0.8821 x 100 |
| Day's range | 0.8294 - 0.8539 |
| 52-week range | 0.7950 - 3.2800 |
| Volume | |
| Avg. volume | 76,807 |
| Market cap | 60.798M |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6200 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.30 |
Business WireHyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
GUILFORD, Conn., April 23, 2024--Hyperfine, Inc. at ISMRM with 17 abstracts assessing the potential of using Swoop® System images across multiple care settings and clinical conditions
Business WireLeading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
GUILFORD, Conn., April 17, 2024--Leading institutions enroll first Alzheimer’s patients receiving amyloid-targeting therapy in CARE PMR study
GlobeNewswireHyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2023 financial results and provided a business update. “I am pleased with our strong growth in 2023. We continued to drive adoption in our beachhead markets of critical care and pediatrics, and
